DreamPharm Products:
Lutein-20||Herbs for headache, fever, and migraine ||
Milk thistle||Saw palmetto||
Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract||
Ginseng and Ginkgo||Hair Million||
DHEA||Coenzyme Q10||
Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.||
Weight loss herbal formula for menopause and pms||Ginkgo biloba||
Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver
Fatty acids resources:
Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 ||
Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5
|| Follicle and follicular cells research abs 1
|| Interferon research abs 1
|| Hemoglobin research abs
ASAIO J. 2002 Nov-Dec;48(6):631-5.
A comparative in vitro hemolysis study of a pulsating intravenous artificial lung.
Lund LW, Hattler BG, Federspiel WJ.
Department of Surgery, University of Pittsburgh PA 15219, USA.
A study was conducted to measure and compare the levels of hemolysis generated by an intravenous membrane oxygenation device referred to as the Intravenous Membrane Oxygenator (IMO) in previous literature. The device is comprised of several hundred hollow fiber membranes of approximately 40 cm in length that are woven in a fabric and wrapped around a centrally positioned balloon. The balloon, which is similar in shape and volume to an intra-aortic balloon, is rapidly inflated and deflated up to 300 bpm to augment gas exchange. To evaluate the hemolytic nature of this device, an in vitro test system was developed, consisting of two identical test loops, each incorporating a device test section of 1 inch in diameter, a heat exchanger, a Biomedicus pump head, a compliance bag, a venous reservoir bag, and Tygon tubing. Both loops were primed with 1.5 L of a bovine blood solution and run simultaneously at 37 degrees C for 6 hours at 4 L/min. Hematocrit and plasma free hemoglobin concentration were measured every 30 minutes to monitor hemolysis within each loop. This methodology was used to compare the hemolysis of the device at maximal pulsation with that of the control loop with an empty test section, as well as with a pulsing balloon of the same volume without any fibers. The results suggest that the hemolytic nature of the pulsating intravenous oxygenator is consistent with that of an intra-aortic balloon, a clinically used device not associated with any complications due to hemolysis.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12455773&dopt=Abstract
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Aug;65(8):392-7.
Correlation between serum transferrin level and prognosis in patients receiving total parenteral nutrition.
Kung SP, Lui WY.
Department of Surgery, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC. spkunghtpe.gov.tw
BACKGROUND: Transferrin is a useful index of visceral protein, but it is unknown whether changes in the level of transferrin can be used as a prognostic marker for patients receiving nutrition support. METHODS: Consecutive in one-year period, we recorded the data of 325 patients who with unusable gastrointestinal tract received total parenteral nutrition (TPN) for more than 2 weeks. The data included the levels of serum transferrin, albumin, total bilirubin, hemoglobin and white blood cell before and after 2-week nutrition support. Age, sex, body weight, diagnosis, and hospital outcome were also recorded. A total of 305 patients with complete initial data and 221 patients with data on TPN-induced level change were enrolled and evaluated statistically. RESULTS: The mortality rate was 47.6% in the group of patients who showed no increase of serum transferrin after 2 weeks of TPN. Univariate analysis revealed that the initial level and TPN-induced changes of serum transferrin, albumin and total bilirubin were significantly correlated with patient survival. However, multivariate analysis showed that the initial level of transferrin, albumin, total bilirubin and the TPN-induced level changes in transferrin were independent factors significantly correlated with patient survival. Two of the most the significant factors among them were initial level of transferrin (p < 0.0001, odds ratio = 2.4838) and change in serum transferrin level after 2 weeks of TPN (p < 0.0001, odds ratio = 2.664). CONCLUSIONS: Changes in serum transferrin level in patients with intestinal failure who received TPN for 2 weeks appear to be a good indicator of patient outcome.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12455809&dopt=Abstract
Anesth Analg. 2002 Dec;95(6):1547-56, table of contents.
Influence of rate and volume of infusion on the kinetics of 0.9% saline and 7.5% saline/6.0% dextran 70 in sheep.
Brauer LP, Svensen CH, Hahn RG, Kilicturgay S, Kramer GC, Prough DS.
Department of Anesthesiology, University of Texas Medical Branch, Galveston 77555, USA.
We examined whether volume kinetic variables obtained during infusion of a short bolus of 0.9% saline (NS) or 7.5% saline/6.0% dextran 70 (HSD) predict the dilution-time curve resulting from a 20-min infusion of the same fluid. Each of six conscious, splenectomized sheep (mean body weight, 36 +/- 3 kg), on 4 different days, in a random order, received each of 4 IV boluses: NS at a rate of 1.2 mL. kg(-1). min(-1) over 5 min or 20 min or 4.0 mL/kg of HSD over 2 min or 20 min. One, 2, and 3-volume kinetic models were fitted to the dilution of the arterial hemoglobin concentration and the urinary excretion as sampled during 180 min. The maximum dilution of arterial plasma at the end of the 5-min and 20-min infusions of NS was approximately 10% and 22%, respectively, and after the 2-min and 20-min infusions of HSD, maximum dilution was 24% and 21%, respectively. The median absolute performance error was virtually identical when the mean variable estimates from the 5-min infusion of NS were used to predict the individual dilution-time curves of the 5-min (mean, 0.027 dilution units) and 20-min (mean, 0.027) infusions and when the 2-min infusion of HSD was used to predict the dilution during the individual 2-min (mean, 0.050) and 20-min infusions (mean, 0.047). Computer simulations indicated that the difference at the end of infusion between the volume effects of NS and HSD is larger after longer infusions. We concluded that the volume kinetic variables obtained during a short infusion can be used to predict the outcome of a longer one, even if the longer infusion also delivers a larger volume. IMPLICATIONS: Kinetic analysis of a short infusion of 7.5% saline/6% dextran or 0.9% saline accurately predicts the effects of a longer infusion of the same volume (7.5% saline/6% dextran) or of a larger volume (0.9% saline).
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12456414&dopt=Abstract
Pediatr Cardiol. 2003 Mar-Apr;24(2):122-6. Epub 2002 Dec 04.
Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
Division of Rheumatology, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.
The objective of this study was to determine predictive factors in children with Kawasaki disease (KD) with which we could distinguish the patients with KD who are either at very low risk or at very high risk for coronary artery inflammation (i.e., either patients who do not need intravenous immunoglobulin treatment or patients in whom more aggressive or even experimental therapies should be considered). Prospectively collected demographic, clinical, and laboratory data on 344 patients treated for KD were correlated with the patients' echocardiographic findings. The parameters studied were age, sex, duration of the fever, erythrocyte sedimentation rate, hemoglobin, white blood cell count, platelet count, and serum albumin. These were examined both in bivariable comparisons and in multiple logistic regression models. Low serum albumin, age <1 year, and the duration of the fever prior to treatment were risk factors for coronary arteritis. In the multivariable models, their combined predictive value for coronary lesions was poor, especially when identifying the patients at a low risk for coronary artery lesions (CALs). In fact, 44 of 98 patients with CALs were falsely classified to the low-risk group. Ten of 14 patients younger than 1 year of age, who also had low serum albumin (<30 g/L), had echocardiographically verified CALs, and 7 (50%) had a definite coronary artery aneurysm. We could not distinguish a group at such a low risk that these patients could be left untreated. Young patients with low albumin run a very high risk for CALs.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12457252&dopt=Abstract
Pediatr Cardiol. 2003 Mar-Apr;24(2):145-8. Epub 2002 Dec 04.
Immunoglobulin failure and retreatment in Kawasaki disease.
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Prannok Road, Bangkok, Thailand 10700.
Several cases of Kawasaki disease (KD) were unresponsive to the initial treatment with intravenous immunoglobulin (IVIG). We retrospectively analyzed all children admitted with KD to determine the occurrence and variables associated with the initial IVIG treatment failure. All patients who fulfilled the criteria for KD and were treated with a single dose (2 g/kg) of IVIG between January 1995 and August 2001 were enrolled. An analysis of the patients who had initially failed to respond to IVIG was performed. A total of 120 patients were enrolled during the study period. There were 68 boys (56.7%). Fourteen patients (11.6%) were found to be unresponsive to initial IVIG treatment. Patients who were anemic (Hb<10 G/DL), had a high neutrophil count (> 75%), a high band count, and low albumin were at risk of failure to respond to a single dose of IVIG. We found no correlation among age, gender, days since starting IVIG treatment, and erythrocyte sedimentation rate (ESR) with failure of the initial IVIG treatment. There were 12 patients (10%) who developed coronary artery aneurysms. The failure of a single dose of IVIG treatment occured in up to 11.6% of our Kawasaki patients. We found that low hemoglobin (<10 G/DL), high neutrophil count (> 75%), high band count, and a low albumin were associated with the requirement for retreatment with a second dose of IVIG.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12457253&dopt=Abstract
Natural Herbal Supplement: Hair Million
Hair Loss, or alopecia is a concern
for increasing number of folks in aging society. Loss of hair is a visible problem, and affects the appearance and changes identity of a person.
The phenomenon of hair thinning and hair loss is most commonly associated with natural aging, although there are many other causes of hair loss, which include inherited or genetic conditions, illnesses, malnutrition, stress, hormonal problems, chemotherapy, and use of some drugs.
Hair growth is a sophisticated biological process, which has not yet been completely understood. A multitude of therapeutic measures, including drugs, surgery, and suppelements have been made available, and used. However, due to the heterogeneity in the underlying cause, there is no perfect cure for all hair loss cases. Most of chemical drugs and hair transplantation surgeries are not free from varying degrees of undesirable side effects on health.
Hair Million is an alternative solution to hair loss problems. Anecdotally, it shows prositive results and improvement for age-related hair thinning and hair loss for a fraction of people who take it. We do not know the mechanisms of action as to how Hair Million works to help stop hair loss, and promote hair growth. We only know by anecdotal observations. There has been no clinical trials nor placebo controlled statistical analysis on the efficacy of Hair Million on hair loss and hair growth. However, there are two merits in this hair restoration herbal formula:
Firstly, Hair Million is rather inexpensive, and secondly, it is made of well known herbs that are safe when consumed in regular quantities.
DHEA is a natural hormone, and it is produced in our body by the adrenal glands.
DHEA has been suggested to provide numerous potential benefits. DHEA (or dehydroepiandrosterone) is converted into androgens (male hormones)
or estrogens (female hormones) in the cells.
DreamPharm Online Healthy Supplements ||
Lutein ||
Celexa Online || Paxil Online || Buspar Online || Tramadol Online || Flexeril Online ||
Natural herbal formula for hair loss problems ||